Is Cellyan Biotechnology Co Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Cellyan Biotechnology Co Ltd (HKPD) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Cellyan Biotechnology Co Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Cellyan Biotechnology Co Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Cellyan Biotechnology Co Ltd?

Muslim investors may consider investing in Cellyan Biotechnology Co Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Cellyan Biotechnology Co Ltd classified as HALAL?

Musaffa determines the Shariah status of Cellyan Biotechnology Co Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Cellyan Biotechnology Co Ltd updated?

The Shariah compliance status of Cellyan Biotechnology Co Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Cellyan Biotechnology Co Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Cellyan Biotechnology Co Ltd?

You can check the latest Shariah compliance status of Cellyan Biotechnology Co Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

HKPD Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: March 30, 2026

Report Source: 2026 2nd Quarter Report

Cellyan Biotechnology Co Ltd. Stock Analysis HKPD

United States Industrials Nano Cap Report: Q2, 2026

Cellyan Biotechnology Ltd. engages in providing pharmaceutical cross-border e-commerce supply chain services. The company employs 27 full-time employees The company went IPO on 2025-01-15. The firm mainly provides two services. The supply chain services mainly provide OTC pharmaceutical cross-border e-commerce supply chain services. The procurement and distribution services mainly provide OTC pharmaceutical cross-border procurement and distribution services.

Key Statistics of Cellyan Biotechnology Co Ltd (HKPD)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.53$0.59

Today's Open

$0.54

Volume

28.13K

P/E Ratio (TTM)

52 Week Range

$0.37$2.76

Market Cap

7.37M

Avg. Volume

296.11K

Dividend Yield

Financial Metrics & Statements of Cellyan Biotechnology Co Ltd (HKPD)

FAQ's for Cellyan Biotechnology Co Ltd (HKPD)

According to Musaffa’s Shariah screening methodology, Cellyan Biotechnology Co Ltd (HKPD) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.